Traders purchased shares of Clorox Co (NYSE:CLX) on weakness during trading on Monday. $47.22 million flowed into the stock on the tick-up and $32.26 million flowed out of the stock on the tick-down, for a money net flow of $14.96 million into the stock. Of all equities tracked, Clorox had the 31st highest net in-flow for the day. Clorox traded down ($0.85) for the day and closed at $127.95

CLX has been the subject of several recent analyst reports. Deutsche Bank initiated coverage on Clorox in a research report on Wednesday, December 13th. They set a “hold” rating and a $142.00 target price for the company. Wells Fargo & Co reiterated a “hold” rating and issued a $130.00 price target on shares of Clorox in a report on Wednesday, December 13th. Consumer Edge upgraded Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Morgan Stanley lowered their price target on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday, November 2nd. Finally, Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and set a $155.00 price target for the company in a report on Thursday, January 4th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $132.46.

The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86. The company has a market capitalization of $16,560.00, a price-to-earnings ratio of 21.08, a price-to-earnings-growth ratio of 2.41 and a beta of 0.31.

Clorox (NYSE:CLX) last posted its earnings results on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. Clorox’s revenue was up .7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.14 earnings per share. equities research analysts predict that Clorox Co will post 6.23 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th were issued a dividend of $0.84 per share. The ex-dividend date of this dividend was Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a yield of 2.63%. Clorox’s dividend payout ratio is currently 55.35%.

In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares in the company, valued at $4,742,260.67. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.00% of the stock is owned by corporate insiders.

Institutional investors have recently bought and sold shares of the business. JPMorgan Chase & Co. lifted its holdings in Clorox by 63.2% during the third quarter. JPMorgan Chase & Co. now owns 417,347 shares of the company’s stock worth $54,269,000 after buying an additional 161,555 shares during the period. Vident Investment Advisory LLC acquired a new position in shares of Clorox during the third quarter worth $1,477,000. Shell Asset Management Co. increased its position in shares of Clorox by 102.5% during the third quarter. Shell Asset Management Co. now owns 119,382 shares of the company’s stock worth $11,465,000 after purchasing an additional 60,427 shares in the last quarter. Allianz Asset Management GmbH increased its position in shares of Clorox by 417.8% during the third quarter. Allianz Asset Management GmbH now owns 63,868 shares of the company’s stock worth $8,425,000 after purchasing an additional 51,534 shares in the last quarter. Finally, Jensen Investment Management Inc. increased its position in shares of Clorox by 12.1% during the fourth quarter. Jensen Investment Management Inc. now owns 40,960 shares of the company’s stock worth $6,092,000 after purchasing an additional 4,435 shares in the last quarter. Institutional investors own 73.42% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://theolympiareport.com/2018/02/12/traders-buy-shares-of-clorox-clx-on-weakness.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.